Ferumoxytol + Gadobutrol
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 19/100
19
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
IC - Interstitial Cystitis
Conditions
IC - Interstitial Cystitis
Trial Timeline
Mar 29, 2023 → May 20, 2025
NCT ID
NCT05811377About Ferumoxytol + Gadobutrol
Ferumoxytol + Gadobutrol is a phase 1 stage product being developed by Lipella Pharmaceuticals for IC - Interstitial Cystitis. The current trial status is completed. This product is registered under clinical trial identifier NCT05811377. Target conditions include IC - Interstitial Cystitis.
What happened to similar drugs?
1 of 5 similar drugs in IC - Interstitial Cystitis were approved
Approved (1) Terminated (2) Active (3)
✅Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mgJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05811377 | Phase 1 | Completed |
Competing Products
20 competing products in IC - Interstitial Cystitis